Cranbury, NJ, United States of America

Ismat Ullah


 

Average Co-Inventor Count = 2.2

ph-index = 7

Forward Citations = 241(Granted Patents)


Company Filing History:


Years Active: 1999-2012

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Celebrating the Innovations of Ismat Ullah

Introduction

Ismat Ullah is a distinguished inventor based in Cranbury, NJ, recognized for her contributions to pharmaceutical formulations and drug delivery systems. With a remarkable portfolio of 10 patents, she has demonstrated a commitment to creating advanced solutions that enhance the efficacy and palatability of medications.

Latest Patents

Among her impressive innovations, Ismat's latest patents include bioavailable capsule compositions of amorphous alpha-(N-sulfonamido)acetamide compound. This patent focuses on pharmaceutical capsule compositions containing an active compound, such as (2R)-2-[[(4-chlorophenyl)sulfonyl][[2-fluoro-4-(1,2,4-oxadiazol-3-yl)phenyl]methyl]amino]-5,5,5-trifluoropentanamide, along with polyethylene glycol (PEG), Vitamin E polyethylene glycol succinate, and polyvinylpyrrolidone (PVP). Additionally, she developed a palatable oral suspension method for a dry powder that forms a pleasant medication when mixed with water, avoiding the bitter taste typically associated with many pharmaceuticals. This innovation entails using a pH modifying agent, such as L-arginine, to facilitate better user experience in administration.

Career Highlights

Ismat Ullah currently contributes her expertise to Bristol-Myers Squibb Company, where she focuses on developing innovative pharmaceutical solutions. Her wealth of experience in drug formulation has earned her a pivotal role in advancing the company's product offerings, particularly in enhancing patient compliance through better-tasting drug delivery forms.

Collaborations

Ismat has collaborated with notable colleagues, including Gary J. Wiley and Nemichand B. Jain, bringing together a wealth of knowledge and diverse expertise to further pharmaceutical innovations. These collaborative efforts play a significant role in refining drug formulations and delivery mechanisms within the company.

Conclusion

Ismat Ullah continues to pave the way in the realm of pharmaceutical invention, showcasing her dedication to improving healthcare outcomes. Through her innovative patents and collaborative spirit, she has made a lasting impact on the industry, contributing to the development of more effective and user-friendly medication alternatives.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…